about
Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway[Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group].Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.NFκB in the development of endothelial activation and damage in uremia: an in vitro approachWhat is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romanceInternalization of tissue factor by platelets.Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodThe role of the endothelium in the short-term complications of hematopoietic SCT.The pharmacokinetics of edoxaban for the prevention and treatment of venous thromboembolism.Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum.Role of sodium tungstate as a potential antiplatelet agent.Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.Haemodialysis through a cellulose membrane induces dephosphorylation of CD11b and promotes leukocyte adhesion to endothelial cells.Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.Automated preparation of whole blood-derived platelets suspended in two different platelet additive solutions and stored for 7 days.Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide.TLR4 and NALP3 inflammasome in the development of endothelial dysfunction in uraemia.Efficient tyrosine phosphorylation of proteins after activation of platelets with thrombin depends on intact glycoprotein Ib.Inhibition of tyrosine kinase activity prevents the adhesive and cohesive properties of platelets and the expression of procoagulant activity in response to collagen.The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.Indoxyl sulfate, a uremic trigger for platelets.Endothelial damage is aggravated in acute GvHD and could predict its development.Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.Vorapaxar for the reduction of atherothrombotic events.In vitro evaluation of the hemostatic effectiveness of cryopreserved platelets.Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers.Internalization of Tissue Factor-Rich Microvesicles by Platelets Occurs Independently of GPIIb-IIIa, and Involves CD36 Receptor, Serotonin Transporter and Cytoskeletal Assembly.Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responsesSerotonergic mechanisms: a potential link between affective disorders and cardiovascular riskMobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and strokeReversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor ConcentratesTissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIaEffects of etamsylate on equine platelets: in vitro and in vivo studiesSafety concerns about perisurgical epoetin treatment: should we add antiplatelet drugs to perisurgical epoetin alfa treatment?Defibrotide prevents the activation of macrovascular and microvascular endothelia caused by soluble factors released to blood by autologous hematopoietic stem cell transplantationEndothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantationRelative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating bloodEndothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarctionThe secretory mechanisms in equine platelets are independent of cytoskeletal polymerization and occur through membrane fusionPlatelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro
P50
Q28276490-97F6D98A-1508-4DAB-943A-130E11B53B9CQ33418938-836B433D-AD47-4C53-9657-29C9BFEE7FC4Q33421577-37C504E9-ACC1-40DD-A2EB-DE13282A9AE0Q34399116-1B03E454-ABDE-46D1-B90A-7091AD85AAD1Q36755496-B7A3F81F-881D-46F7-A5C8-1158D346BAB0Q37240164-032ABC04-0359-4915-98FF-99E28E82D6E1Q37297475-4EFA09FD-68A4-4718-BAE7-128E70E2EBDCQ37860915-BFAD056B-4701-450F-844C-2B930CE5E877Q38182640-93CF91F0-3A84-46C8-B7A7-67D1F9846605Q40109676-F34BD7FE-F376-4631-8389-987682FA8D5EQ42024923-ABF02575-6B59-45EE-B329-48429EF1E72BQ42112270-D7B20180-72B4-4F0D-BC39-476C3A644697Q42448573-CD321DD4-B1D1-41EC-B256-A1BDF205633FQ43275188-2BEBCDF5-E197-4B38-BE97-74D6CA3C6043Q43587730-627B03FD-0475-4E95-8EA0-286C72136EA0Q44840961-D803F07B-ACBB-4239-B817-BE530DCC5FFDQ46800130-C457375D-7670-40E1-BC5D-22EC923512B4Q46803554-2360B2C8-8CBE-41F6-A8A1-B56B0655DDDAQ46975591-AD9F983E-EDC7-4543-82E7-2202937610DFQ48019681-1E3B48FB-9090-451E-8C58-97326119E1EDQ48155683-13F50D0E-73DA-4244-9724-7F2E969EC0A8Q48222811-EFBDA493-A9D1-4AA1-8419-86CB43EA10B2Q48324679-455A81B0-02F2-4995-A0C2-5E3A95C2A689Q52981265-663459C1-083D-4330-BD06-26A26CFC66AFQ53317633-B30B6749-ACC8-491E-B083-A37DDCD95501Q53538359-709C0BE8-1912-416A-9568-20A008AC3E18Q54256171-A13AC7CA-7F6F-439C-9B43-16DAEEC63DCEQ59421710-8DCD9B5D-8CDD-43F4-958B-98BDEC4471B0Q59570462-7C3BA12D-0457-4111-8E11-FD5F58B7748CQ61771939-D36A89A4-397E-4E14-ACF9-AB6287BCAE2EQ61914311-ACAC10FC-0D40-4DF0-9518-24FB6F9A94E1Q79693387-84C23CE3-FDE9-4258-B438-7801075F5FA7Q80098509-461F10F1-5771-4517-8853-7959E681244BQ80747769-6F459F30-1A2F-4349-9DC0-9DE6A9BA1ED8Q82711209-45696FED-F714-458B-892B-7B9B1AE4CB8BQ82954860-FBC7D91B-988C-42AB-9AD7-414D3EAA67ACQ84136152-6E65E5CB-481C-4FA8-B180-3D67E804B44EQ84528391-77791B67-FD1B-4B3D-A009-03F676A16989Q85218188-9A396847-189C-4E53-9DF7-EA9B84826DF6Q85350696-3F112A0E-0951-424A-96C8-A7B223D04483
P50
description
researcher ORCID ID = 0000-0003-1122-0052
@en
wetenschapper
@nl
name
Maribel Diaz-Ricart
@ast
Maribel Diaz-Ricart
@en
Maribel Diaz-Ricart
@es
Maribel Diaz-Ricart
@nl
type
label
Maribel Diaz-Ricart
@ast
Maribel Diaz-Ricart
@en
Maribel Diaz-Ricart
@es
Maribel Diaz-Ricart
@nl
prefLabel
Maribel Diaz-Ricart
@ast
Maribel Diaz-Ricart
@en
Maribel Diaz-Ricart
@es
Maribel Diaz-Ricart
@nl
P106
P31
P496
0000-0003-1122-0052